Read on Twitter
This is not unusual in trials, and it’s appropriate to proceed with caution. It’s a hold/pause, not the end. An “adverse event” could even be an unfortunate coincidence. We’ll find out soon enough.
What’s is unusual is having research and clinical trials done under such immense pressure and public attention.
Biomed research rarely (if ever) follows a linear path. It’s not like the movies.
You’re all getting to see it play out in real time. The hiccups, hurdles and backtracks are a normal part of the process, they’re just being magnified and amplified under the circumstances.
You’re all getting to see it play out in real time. The hiccups, hurdles and backtracks are a normal part of the process, they’re just being magnified and amplified under the circumstances.
